GB2574659A - Immediate workup - Google Patents

Immediate workup Download PDF

Info

Publication number
GB2574659A
GB2574659A GB1809796.4A GB201809796A GB2574659A GB 2574659 A GB2574659 A GB 2574659A GB 201809796 A GB201809796 A GB 201809796A GB 2574659 A GB2574659 A GB 2574659A
Authority
GB
United Kingdom
Prior art keywords
medical
analysing
medical images
scan
output data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1809796.4A
Other versions
GB201809796D0 (en
Inventor
Kecskemethy Peter
Karpati Edith
Rijken Tobias
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kheiron Medical Technologies Ltd
Original Assignee
Kheiron Medical Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kheiron Medical Technologies Ltd filed Critical Kheiron Medical Technologies Ltd
Priority to GB1809796.4A priority Critical patent/GB2574659A/en
Publication of GB201809796D0 publication Critical patent/GB201809796D0/en
Priority to EP19744779.0A priority patent/EP3806746B1/en
Priority to CA3102173A priority patent/CA3102173A1/en
Priority to HUE19744777A priority patent/HUE058687T2/en
Priority to SI201930234T priority patent/SI3806744T1/en
Priority to US17/251,354 priority patent/US11410307B2/en
Priority to ES19744777T priority patent/ES2914387T3/en
Priority to JP2020568666A priority patent/JP2021527472A/en
Priority to AU2019285392A priority patent/AU2019285392A1/en
Priority to EP19744778.2A priority patent/EP3806745B1/en
Priority to ES19744779T priority patent/ES2914873T3/en
Priority to AU2019285393A priority patent/AU2019285393B2/en
Priority to CA3102174A priority patent/CA3102174C/en
Priority to DK19744778.2T priority patent/DK3806745T3/en
Priority to PCT/GB2019/051667 priority patent/WO2019239154A1/en
Priority to ES19744778T priority patent/ES2914415T3/en
Priority to SI201930235T priority patent/SI3806745T1/en
Priority to JP2020568814A priority patent/JP2021527478A/en
Priority to CA3102170A priority patent/CA3102170A1/en
Priority to US17/251,398 priority patent/US11455723B2/en
Priority to SI201930248T priority patent/SI3806746T1/en
Priority to DK19744779.0T priority patent/DK3806746T3/en
Priority to HUE19744779A priority patent/HUE058907T2/en
Priority to US17/251,417 priority patent/US11488306B2/en
Priority to JP2020568668A priority patent/JP2021527473A/en
Priority to EP19744777.4A priority patent/EP3806744B1/en
Priority to PCT/GB2019/051666 priority patent/WO2019239153A1/en
Priority to PCT/GB2019/051668 priority patent/WO2019239155A1/en
Priority to AU2019285394A priority patent/AU2019285394A1/en
Priority to DK19744777.4T priority patent/DK3806744T3/en
Publication of GB2574659A publication Critical patent/GB2574659A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00ICT specially adapted for the handling or processing of medical images
    • G16H30/40ICT specially adapted for the handling or processing of medical images for processing medical images, e.g. editing
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20081Training; Learning
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T2207/00Indexing scheme for image analysis or image enhancement
    • G06T2207/20Special algorithmic details
    • G06T2207/20084Artificial neural networks [ANN]
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H30/00ICT specially adapted for the handling or processing of medical images
    • G16H30/20ICT specially adapted for the handling or processing of medical images for handling medical images, e.g. DICOM, HL7 or PACS

Abstract

A computer-aided method of analysing medical images such as mammographic or X-ray scans in substantially real-time, the method comprises the steps of: receiving one or more medical images; analysing said medical images to determine one or more characteristics; and generating output data based on the determined characteristics, wherein the output data is indicative of a requirement to obtain one or more additional medical tests. The one or more additional medical tests may comprise any or any combination of: a computerised tomography (CT) scan; an ultrasound scan; a magnetic resonance imaging (MRI) scan; a tomosynthesis scan; and/or a biopsy. The medical images may be analysed by feeding them through a trained machine learning model, such as a Convolutional Neural Network. In an alternative embodiment a system for analysing medical images in substantially real-time includes a medical imaging device 101, a picture archiving communication system (PACS) 102; and a processing unit operable to analyse the medical images on the PCAS to determine one or more characteristics.

Description

IMMEDIATE WORKUP
Field
The present invention relates to deep learning implementations for medical imaging. More particularly, the present invention relates to a method and system for indicating whether additional medical tests are required after preliminary analysis during an initial medical screening, in substantially real-time.
Background
Mammography is an advanced method of scanning human breast tissue which makes use of low dose X-rays to produce images of the internal structure of the human breast. The screening of these images, called mammograms, aids early detection and diagnoses of breast abnormalities and diseases. In order to ascertain a more accurate scan, mammogram machines usually have two plates that compress the breast to spread the tissue apart and help radiologists examine the mammogram.
Assessment by human manpower, believed to be the most accurate method of image evaluation, refers to the task performed by a radiologist or similar professional, of inspecting medical scans, section by section, for a comprehensive analysis. However, considering a mammogram is a representation of three-dimensional information projected onto a twodimensional image plane, there is often superimposition of tissues in the 2D medical scan images (mammograms) being inspected. As a result, tissues that appear superimposed within the image of the breast can reduce the visibility of malignant abnormalities or sometimes even simulate the appearance of an abnormality (false positive). This makes the task of analysing a mammogram more challenging and can cause difficulty when it comes to accurately and precisely detecting abnormalities.
Thus, the current methods of screening and requesting a workup (further medical tests including for example using alternative imaging techniques) can be inefficient and/or slow when relying on radiologist alone to examine unclear mammograms. Often, the end result is an unnecessary and costly recall procedure, biopsy and/or psychological stress for patients.
Additionally, if there is a suspicious finding in a mammogram and a further test is required, under the current medical screening regimes, the call back time for an additional test is usually two to three weeks.
Summary of Invention
Aspects and/or embodiments seek to provide a method and system for recommending or indicating the requirement for additional medical tests, in substantially real-time, based on analysing an initial medical scan, with the use of deep learning.
According to a first aspect, there is provided a computer-aided method of analysing medical images in substantially real-time, the method comprising the steps of: receiving one or more medical images; analysing said one or more medical images to determine one or more characteristics; and generating output data based on the determined one or more characteristics, wherein the output data is indicative of a requirement to obtain one or more additional medical tests.
Conventional methods for analysing medical images and making a decision to ascertain further medical tests rely on experts, usually a radiologist, to identify an abnormality in a mammogram. Often, there is a delay for the radiologist to examine the mammogram. Further radiologists do not demonstrate consistent accuracy due to the manual nature of the task, for example, making errors due to superimposed breast tissues in the mammogram and/or details too fine for the human eye to detect. Conversely, the method disclosed herein provides a way to analyse a medical image without any human input and provide an instantaneous recommendation as to whether a further medical test is required.
Optionally, the one or more additional medical tests comprise any or any combination of: a computerised tomography (CT) scan; an ultrasound scan; a magnetic resonance imaging (MRI) scan; a tomosynthesis scan; and/or a biopsy.
A further medical test can be suggested based on the analysis of the preliminary screening. As an example, a more detailed tomosynthesis scan can be instantaneously recommended if the initial mammogram is unclear or features are superimposed or there might be a lesion worth investigating. In some cases, the analysis from the initial medical image may not require any further workup or medical tests. Optionally, the output data may also indicate a breast density or tissue classification type.
Optionally, the one or more medical images comprises one or more mammographic or X-ray scans.
In most medical screening programmes, X-ray or mammography is the first type of medical scan.
Optionally, the step of analysing and determining is performed using one or more trained machine learning models.
Trained machine learning models can analyse medical images far quicker than a human expert, and hence increase the number of medical images analysed overall. The accuracy is typically consistent when using a machine learning model. Thus a problem, for example the growth of a cancerous tumour, can be detected more quickly than waiting for a human expert to become available and hence treatment may begin earlier or an additional medical test may be requested sooner. The identification of regions of interest, which may include lesions, may therefore aid screening and clinical assessment of breast cancer among other medical issues. Earlier diagnosis and treatment can reduce psychological stress to a patient and also increase the chances of survival in the long term.
Optionally, the trained machine learning models comprise convolutional neural networks.
Convolutional networks are powerful tools inspired by biological neural processes, which can be trained to yield hierarchies of features and are particularly suited to image recognition. Convolutional layers apply a convolutional operation to an input and pass the results to a following layer. With training, convolutional networks can achieve expert-level accuracy or greater with regard to segmenting and localising anatomical and pathological regions in digital medical images such as mammograms.
Optionally, the step of analysing and determining comprises segmenting one or more anatomical regions. Optionally, the output data further comprises overlay data indicating a segmentation outline and/or a probability masks showing one or more locations of one or more segmented regions.
Providing a clear and accurate segmentation of regions can be very helpful when reviewing a medical image, such as a mammogram. This may be especially relevant if there is reason to suspect there is a medical issue with a patient, for example a swollen area which is larger than it was in previous scans. Such changes may be more easily detectable if the different regions are clearly segmented. In addition, the segmentation information can also be used to enrich the Picture Archiving Communication Systems (PACS) that radiology departments use in hospitals. With the inclusion of this segmentation data on PACS, it advantageously improves future methods of flagging up similar cases, whether the methods are semi-automated, entirely automated or performed manually.
Optionally, the step of analysing and determining comprises identifying tissue type and density category. Optionally, the required type of the one or more additional medical tests are dependent upon the density category determined based on the one or more medical images. Optionally, this step may jointly estimate tissue type and density category.
Correctly classifying the tissue type and density category can enable the method to recommend an appropriate additional medical test or specific workup.
Optionally, the step of analysing and determining comprises automatically identifying one or more anomalous regions in the medical image.
Optionally, the step of analysing and determining comprises identifying and distinguishing between a malignant lesion and/or a benign lesion and/or typical lesion.
Optionally, the output data further comprises overlay data indicating a probability mask for the one or more lesions.
Optionally, the step of analysing and determining comprises identifying architectural distortion.
Optionally, the one or more medical images and the one or more additional medical images comprise the use digital imaging and communications in medicine, DICOM, files.
As a DICOM file is conventionally used to store and share medical images, conforming to such a standard can allow for easier distribution and future analysis of the medical images and/or any overlays or other contributory data. The one or more binary masks may be stored as part of a DICOM image file, added to an image file, and/or otherwise stored and/or represented according to the DICOM standard or portion of the standard.
According to a further aspect, there is provided a system for analysing medical images in substantially real-time, the system comprising: a medical imaging device; a picture archiving communication system, PACS; a processing unit operable to analyse one or more medical images on the PACS to determine one or more characteristics; and an output viewer operable to display output data generated based on the determined one or more characteristics, wherein the output data is indicative of a requirement to obtain one or more additional medical images.
Such a system may be installed in or near hospitals, or connected to hospitals via a digital network, to reduce waiting times for medical images to be analysed. Patients may therefore be spared stress from not knowing the results of a medical scan and receive a decision more quickly.
Optionally, the processing unit is integrated with the medical imaging device.
In this way, the medical scanner can be coupled with a processing unit to analyse medical images as soon as they are scanned.
Optionally, the processing unit is located remotely and is accessible via a communications channel.
In this configuration, the processing unit can be deployed from a remote cloud system without need to replace and change existing scanning equipment.
According to a further aspect, there is provided a system operable to perform the method according to any other aspect.
According to a further aspect, there is provided a computer program operable to perform the method according to any other aspect
Through the use of a computer or other digital technology, examination of medical images may be performed with greater accuracy, speed, and/or reliability that relying on a human expert. Therefore, a greater number of medical images may be reviewed at one time thereby reducing backlogs for experts and further reducing errors made when the medical images themselves are actually reviewed.
Brief Description of Drawings
Embodiments will now be described, by way of example only and with reference to the accompanying drawings having like-reference numerals, in which:
Figure 1 shows a flow diagram of an embodiment;
Figure 2 depicts a first deployment (for example, within a medical scanning device);
Figure 3 depicts a second deployment (for example, on the premises of a medical facility); and
Figure 4 depicts a third deployment (for example, using a cloud system).
Specific Description
Referring to Figures 1 to 4, an embodiment will now be described.
As seen in Figure 1, having performed a medical scan of a patient (such as a mammography) using a medical imaging scanner 101, the scanned images are collated in DICOM format, which is a file format commonly used to store medical images. The method uses preprocessed data that is stored on a Picture Archiving Communication Systems (PACS) 102 that radiology departments use in hospitals. The output of this method also enriches the PACS database to improve future applications of analysing mammographic images. Image data is extracted from the DICOM file and an image is generated.
The image then undergoes a pre-processing stage 103. The image is loaded onto a 4D tensor of size [1, width, height, 1], The pre-processing stage may comprise windowing the image data to a predetermined windowing level. The windowing level defines the range of bit values considered in the image. Medical images are conventionally 16-bit images, wherein each pixel is represented as a 16-bit integer ranging from 0 to 216-1, i.e. [0, 1,2, ..., 65535], The information content is very high in these images, and generally comprises more information than what the human eye is capable of detecting. A set value for the windowing level is typically included within the DICOM file.
In some cases, it can be important to maintain image resolution. Often, conventional graphics processing unit (GPU) constraints require that the image is divided into a plurality of patches in order to maintain resolution. Each patch can then be provided to a Fully Convolutional Network (FCN). The larger the patch, the more context that can be provided but some precision may be lost. For example, in the case of a large image comprising a small tumour, if the FCN is instructed that somewhere in this patch there is a tumour, the network would need to learn how to find it first before it can be classified. In this embodiment patch sizes of 300x300 pixels are used, although larger and smaller patch sizes may be used.
A rescaling step may be included owing to above mentioned constraints of conventional hardware. Medical images are typically in the region of -3500x2500 pixels. An FCN 100 applied to this image does not fit in conventional graphics processing unit (GPU) memory. The image can be rescaled to a larger or smaller size, or even not rescaled at all, and would allow the FCN to see a higher resolution and may pick up finer detail. However, this is unlikely to fit in GPU memory, and could cause the method to become considerably slower. By rescaling the image to a smaller size, it is more likely to be able to fit in a GPU memory, and allow the processes to run at a faster speed. The FCN may also generalise better owing to a smaller number of input parameters.
The method may be used to identify and detect lesions in the mammograms. The lesions which may be segmented may comprise one or more cancerous growths, masses, abscesses, lacerations, calcifications, and/or other irregularities within biological tissue.
The images are analysed by feeding them through a trained machine learning model, such as a Convolutional Neural Network. This embodiment utilises deep learning techniques to train and develop the convolution network. The model is trained on a dataset with known workups and, hence, directly establishes a relationship between the images received and the known workups to estimate a required workup. In particular, the output 105 of the machine learning model is a binary vector, where the indices represent various types of workup. For example, the workups may be any, or any combination of need no further action, an Ultrasound scan, a Tomosynthesis scan, an MRI scan and/or taking a Biopsy.
The dataset used for training the neural networks may also contain known density or tissue types. In that case, a multi-task learning approach can be taken to have the model also output density (A, B, C, D) or tissue type (1, 2, 3, 4, 5).
There are different types of patterns in breast tissue that affect the detectability of breast cancers. Thus, it is important to know what kind of pattern is present. There are five mammography parenchymal patterns known as “Tabar patterns”, named after professor Laszlo Tabar who developed this classification.
The Tabar patterns (or classifications types) are based on a histologic-mammographic correlation with a three-dimensional, subgross (thick-slice) technique, and on the relative proportion of four “building blocks” (nodular densities, linear densities, homogeneous fibrous tissue, radiolucent fat tissue). The five classifications are as follows:
1. Balanced proportion of all components of breast tissue with a slight predominance of fibrous tissue
2. Predominance of fat tissue
3. Predominance of fat tissue with retroareolar residual fibrous tissue
4. Predominantly nodular densities
5. Predominantly fibrous tissue (dense breast)
Classes 4 and 5 are considered high risk, meaning that it is difficult to detect cancers in the breast with those patterns, whereas classes 1,2 and 3 are considered lower risk as it is easier to spot cancerous regions.
Some therapies may alter the pattern by increasing parenchymal density, as in hormone replacement therapy (HRT), or reducing it as in therapies with selective oestrogen-receptor modulators (SERM).
Similarly, breast density categories are classified by radiologists using the BI-RADS system. Again, this classification is used for quality control purposes. For example, it is very difficult to spot an anomaly in dense breasts. There are four categories in the BI-RADS system:
A. The breasts are almost entirely fatty
B. There are scattered areas of fibroglandular density
C. The breasts are heterogeneously dense, which may obscure small masses
D. The breasts are extremely dense, which lowers the sensitivity of mammography
Importantly, breast densities and tissue patterns are also known to have a mutual correlation to breast cancer development.
In some cases, the method can produce two types of output data. Whilst output data can relate to a suggested workup or additional medical tests 105a, the output data may also indicate the density or tissue classification 105b. The output data can indicate a binary output as to the requirement for further tests. Optionally, the output data can include data relating to how the binary output was reached, including any of; Tabar pattern; tissue classification types; breast density; nodular densities; linear densities; homogenous fibrous tissue; radiolucent fat tissue; BI-RADS category; a measure of superimposed features within the images; probability and/or confidence rating.
Mammography is a medical imaging modality widely used for breast cancer detection. Mammography makes use of “soft” X-rays to produce detailed images of the internal structure of the human breast - these images are called mammograms and this method is considered to be the gold standard in early detection of breast abnormalities which provide a valid diagnosis of a cancer in a curable phase.
Unfortunately, the procedure of analysing mammograms is often challenging. The density and tissue type of the breasts are highly varied and in turn present a high variety of visual features due to patient genetics. These background visual patterns can obscure the often tiny signs of malignancies which may then be easily overlooked by the human eye. Thus, the analyses of mammograms often lead to false-positive or false-negative diagnostic results which may cause missed treatment (in the case of false negatives) as well as unwanted psychological and sub-optimal downstream diagnostic and treatment consequences (in the case of false positives).
Most developed countries maintain a population-wide screening program, comprising a comprehensive system for calling in women of a certain age group (even if free of symptoms) to have regular breast screening. These screening programs require highly standardized protocols to be followed by experienced specialist trained doctors who can reliably analyse a large number of mammograms routinely. Most professional guidelines strongly suggest reading of each mammogram by two equally expert radiologists (also referred to as doublereading). Nowadays, when the number of available radiologists is insufficient and decreasing, the double-reading requirement is often impractical or impossible.
When analysing mammograms, the reliable identification of anatomical structures is important for visual evaluation and especially for analytic assessment of visual features based on their anatomic location and their relation to anatomic structures, which may have profound implications on the final diagnostic results. In the case that anatomic structures appear distorted they may also indicate the presence of possible malignancies.
Conventional X-ray is a medical imaging modality widely used for the detection of structural abnormalities related to the air containing structures and bones, as well as those diseases which have an impact on them. Conventional X-ray is the most widely used imaging method and makes use of “hard” X-rays to produce detailed images of the internal structure of the lungs and the skeleton. These images are called roentgenograms or simply X-rays.
Unfortunately, the procedure of analysing X-rays is often challenging, especially when analysing lung X-rays in order to detect infectious disease (e.g. TB) or lung cancer in early stage.
Cross-sectional medical imaging modalities are widely used for detection of structural or functional abnormalities and diseases which have a visually identifiable structural impact on the human internal organs. Generally, the images demonstrate the internal structures in multiple cross-sections of the body. The essence of the most widely used cross-sectional techniques are described below.
Computed tomography (CT) is a widely used imaging method and makes use of “hard” X-rays produced and detected by a specially rotating instrument and the resulted attenuation data (also referred to as raw data) are presented by a computed analytic software producing detailed images of the internal structure of the internal organs. The produced sets of images are called CT-scans which may constitute multiple series with different settings and different contrast agent phases to present the internal anatomical structures in cross sections perpendicular to the axis of the human body (or synthesized sections in other angles).
Magnetic Resonance Imaging (MRI) is an advanced diagnostic technique which makes use of the effect magnetic field impacts on movements of protons which are the utmost tiniest essential elements of every living tissue. In MRI machines the detectors are antennas and the signals are analysed by a computer creating detailed images if the internal structures in any section of the human body. MRI can add useful functional information based on signal intensity of generated by the moving protons.
However, the procedure of analysing any kind of cross-sectional images is often challenging, especially in the case of oncologic disease as the initial signs are often hidden and appearance of the affected areas are only minimally differed from the normal.
When analysing cross sectional scans, diagnosis is based on visual evaluation of anatomical structures. The reliable assessment, especially for analytic assessment, of visual appearance based on their anatomic location and their relation to anatomic structures, may have profound implications on final diagnostic results. In the case that anatomic structures appear distorted they may also indicate the presence of possible malignancies.
Generally, in the case of all diagnostic radiology methods (which include mammography, conventional X-ray, CT, MRI), the identification, localisation (registration), segmentation and classification of abnormalities and/or findings are important interlinked steps in the diagnostic workflow.
In the case of ordinary diagnostic workflows carried out by human radiologists, these steps may only be partially or sub-consciously performed but in the case of computer-based or computer-aided diagnoses and analyses the steps often need to be performed in a clear, concrete, descriptive and accurate manner.
Locality and classification may define and significantly influence diagnoses. Both locality and classification may be informed by segmentation in terms of the exact shape and extent of visual features (i.e. size and location of boundaries, distance from and relation to other features and/or anatomy). Segmentation may also provide important information regarding the change in status of disease (e.g. progression or recession).
Machine learning is the field of study where a computer or computers learn to perform classes of tasks using the feedback generated from the experience or data gathered that the machine learning process acquires during computer performance of those tasks.
Typically, machine learning can be broadly classed as supervised and unsupervised approaches, although there are particular approaches such as reinforcement learning and semi-supervised learning which have special rules, techniques and/or approaches. Supervised machine learning is concerned with a computer learning one or more rules or functions to map between example inputs and desired outputs as predetermined by an operator or programmer, usually where a data set containing the inputs is labelled.
Unsupervised learning is concerned with determining a structure for input data, for example when performing pattern recognition, and typically uses unlabelled data sets. Reinforcement learning is concerned with enabling a computer or computers to interact with a dynamic environment, for example when playing a game or driving a vehicle.
Various hybrids of these categories are possible, such as semi-supervised machine learning where a training data set has only been partially labelled. For unsupervised machine learning, there is a range of possible applications such as, for example, the application of computer vision techniques to image processing or video enhancement. Unsupervised machine learning is typically applied to solve problems where an unknown data structure might be present in the data. As the data is unlabelled, the machine learning process is required to operate to identify implicit relationships between the data for example by deriving a clustering metric based on internally derived information. For example, an unsupervised learning technique can be used to reduce the dimensionality of a data set and attempt to identify and model relationships between clusters in the data set, and can for example generate measures of cluster membership or identify hubs or nodes in or between clusters (for example using a technique referred to as weighted correlation network analysis, which can be applied to highdimensional data sets, or using k-means clustering to cluster data by a measure of the Euclidean distance between each datum).
Semi-supervised learning is typically applied to solve problems where there is a partially labelled data set, for example where only a subset of the data is labelled. Semi-supervised machine learning makes use of externally provided labels and objective functions as well as any implicit data relationships. When initially configuring a machine learning system, particularly when using a supervised machine learning approach, the machine learning algorithm can be provided with some training data or a set of training examples, in which each example is typically a pair of an input signal/vector and a desired output value, label (or classification) or signal. The machine learning algorithm analyses the training data and produces a generalised function that can be used with unseen data sets to produce desired output values or signals for the unseen input vectors/signals. The user needs to decide what type of data is to be used as the training data, and to prepare a representative real-world set of data. The user must however take care to ensure that the training data contains enough information to accurately predict desired output values without providing too many features (which can result in too many dimensions being considered by the machine learning process during training and could also mean that the machine learning process does not converge to good solutions for all or specific examples). The user must also determine the desired structure of the learned or generalised function, for example whether to use support vector machines or decision trees.
The use of unsupervised or semi-supervised machine learning approaches are sometimes used when labelled data is not readily available, or where the system generates new labelled data from unknown data given some initial seed labels.
Machine learning may be performed through the use of one or more of: a non-linear hierarchical algorithm; neural network; convolutional neural network; recurrent neural network; long short-term memory network; multi-dimensional convolutional network; a memory network; fully convolutional network or a gated recurrent network allows a flexible approach when generating the predicted block of visual data. The use of an algorithm with a memory unit such as a long short-term memory network (LSTM), a memory network or a gated recurrent network can keep the state of the predicted blocks from motion compensation processes performed on the same original input frame. The use of these networks can improve computational efficiency and also improve temporal consistency in the motion compensation process across a number of frames, as the algorithm maintains some sort of state or memory of the changes in motion. This can additionally result in a reduction of error rates.
Developing a machine learning system typically consists of two stages: (1) training and (2) production. During the training the parameters of the machine learning model are iteratively changed to optimise a particular learning objective, known as the objective function or the loss. Once the model is trained, it can be used in production, where the model takes in an input and produces an output using the trained parameters.
During training stage of neural networks, verified inputs are provided, and hence it is possible to compare the neural network’s calculated output to then the correct the network is need be. An error term or loss function for each node in neural network can be established, and the weights adjusted, so that future outputs are closer to an expected result. Backpropagation techniques can also be used in the training schedule for the or each neural network.
The model can be trained using backpropagation and forward pass through the network. The loss function for dense training is the sum over spatial dimensions of the loss functions of the individual pixels.
L(%) = Y here L(x) is the loss over the whole image and Z'(Xi,7) is the loss for the pixel at i,j. This enables the system to automatically identify one or more lesions from the image created by the system.
The loss function may be the DICE loss, which is defined as ^siri DSC ^si+^n where s^and ^represent the continuous values of the prediction map e [0,..., l]and the ground truth at each pixel i, respectively. Alternatively, a cross-entropy can be used. The cross-entropy loss for the pixel at i, j is defined as
C
Lce = -^y * iog(s)
C = 1 where C is the number of classes, y e {0,1 }is the binary indicator for class c, andsis the score for class c. The loss for the full image, x, is defined as the sum over all the losses for the pixels:
c
Lce(x) = ^(-^y * iog(s)) i,j c=i
Once an output is generated by the neural network, one or more patches from the output may be sampled. The sampling may be proportional to the probability of the presence of lesions, in particular the sampling may be taken from areas with a higher probability of being a lesion as defined by a predetermined threshold. Alternatively, Poisson sampling or uniform sampling may be used to sample patches. Poisson sampling may give a better coverage of all of the breast tissue. The CNN may also be trained using the results of a different process, for example a Random Forest based candidate selector or any similar lesion detection method.
In the multitask learning setting, the loss will consist of multiple parts. A loss term for each task.
L(x) = λ1Ε1 + A2L2
Where L1,L2 are the loss terms for two different tasks and λ12 are weighting terms.
Any system features as described herein may also be provided as method features, and vice versa. As used herein, means plus function features may be expressed alternatively in terms of their corresponding structure.
Any feature in one aspect may be applied to other aspects, in any appropriate combination. In particular, method aspects may be applied to system aspects, and vice versa. Furthermore, any, some and/or all features in one aspect can be applied to any, some and/or all features in any other aspect, in any appropriate combination.
It should also be appreciated that particular combinations of the various features described and defined in any aspects of the invention can be implemented and/or supplied and/or used independently.

Claims (19)

CLAIMS:
1. A computer-aided method of analysing medical images in substantially real-time, the method comprising the steps of:
receiving one or more medical images;
analysing said one or more medical images to determine one or more characteristics; and generating output data based on the determined one or more characteristics, wherein the output data is indicative of a requirement to obtain one or more additional medical tests.
2. The method of any preceding claim wherein the one or more additional medical tests comprises any or any combination of: a computerised tomography (CT) scan; an ultrasound scan; a magnetic resonance imaging (MRI) scan; a tomosynthesis scan; and/or a biopsy.
3. The method of any preceding claim wherein the one or more medical images comprises one or more mammographic or X-ray scans.
4. The method of any preceding claim wherein the step of analysing and determining is performed using one or more trained machine learning models.
5. The method of claim 4 wherein the trained machine learning models comprise convolutional neural networks.
6. The method of any preceding claim wherein the step of analysing and determining comprises segmenting one or more anatomical regions.
7. The method of claim 6 wherein the output data further comprises overlay data indicating a segmentation outline and/or a probability masks showing one or more locations of one or more segmented regions.
8. The method of any preceding claim wherein the step of analysing and determining comprises identifying tissue type and density category.
9. The method of claim 2 and 8 wherein the required type of the one or more additional medical tests are dependent upon the density category determined based on the one or more medical images.
10. The method of any preceding claim wherein the step of analysing and determining comprises automatically identifying one or more anomalous regions in the medical image.
11. The method of any preceding claim wherein the step of analysing and determining comprises identifying and distinguishing between a malignant lesion and/or a benign lesion and/or typical lesion.
12. The method of claim 11 wherein the output data further comprises overlay data indicating a probability mask for the one or more lesions.
13. The method of any preceding claim wherein the step of analysing and determining comprises identifying architectural distortion.
14. The method of any preceding claim wherein the one or more medical images and the one or more additional medical images comprise the use digital imaging and communications in medicine, DICOM, files.
15. A system for analysing medical images in substantially real-time, the system comprising:
a medical imaging device;
a picture archiving communication system, PACS;
a processing unit operable to analyse one or more medical images on the PACS to determine one or more characteristics; and an output viewer operable to display output data generated based on the determined one or more characteristics, wherein the output data is indicative of a requirement to obtain one or more additional medical images.
16. The system of claim 15 wherein the processing unit is integrated with the medical imaging device.
17. The system of claim 15 wherein the processing unit is located remotely and is accessible via a communications channel.
18. The system of any one of claims 15 to 17 operable to perform the method of any one of claims 1 to 14.
5
19. A computer program product operable to perform the method and and/or system of any preceding claim.
GB1809796.4A 2018-06-14 2018-06-14 Immediate workup Withdrawn GB2574659A (en)

Priority Applications (30)

Application Number Priority Date Filing Date Title
GB1809796.4A GB2574659A (en) 2018-06-14 2018-06-14 Immediate workup
DK19744777.4T DK3806744T3 (en) 2018-06-14 2019-06-14 IMMEDIATE INVESTIGATION
PCT/GB2019/051667 WO2019239154A1 (en) 2018-06-14 2019-06-14 Second reader
JP2020568814A JP2021527478A (en) 2018-06-14 2019-06-14 Second leader
ES19744778T ES2914415T3 (en) 2018-06-14 2019-06-14 second reader
SI201930234T SI3806744T1 (en) 2018-06-14 2019-06-14 Immediate workup
US17/251,354 US11410307B2 (en) 2018-06-14 2019-06-14 Second reader
ES19744777T ES2914387T3 (en) 2018-06-14 2019-06-14 immediate study
JP2020568666A JP2021527472A (en) 2018-06-14 2019-06-14 Second leader suggestion
AU2019285392A AU2019285392A1 (en) 2018-06-14 2019-06-14 Immediate workup
EP19744778.2A EP3806745B1 (en) 2018-06-14 2019-06-14 Second reader
ES19744779T ES2914873T3 (en) 2018-06-14 2019-06-14 second reading suggestion
AU2019285393A AU2019285393B2 (en) 2018-06-14 2019-06-14 Second reader
CA3102174A CA3102174C (en) 2018-06-14 2019-06-14 Second reader suggestion
DK19744778.2T DK3806745T3 (en) 2018-06-14 2019-06-14 SECOND READER
EP19744779.0A EP3806746B1 (en) 2018-06-14 2019-06-14 Second reader suggestion
HUE19744777A HUE058687T2 (en) 2018-06-14 2019-06-14 Immediate workup
SI201930235T SI3806745T1 (en) 2018-06-14 2019-06-14 Second reader
US17/251,417 US11488306B2 (en) 2018-06-14 2019-06-14 Immediate workup
CA3102170A CA3102170A1 (en) 2018-06-14 2019-06-14 Immediate workup
US17/251,398 US11455723B2 (en) 2018-06-14 2019-06-14 Second reader suggestion
SI201930248T SI3806746T1 (en) 2018-06-14 2019-06-14 Second reader suggestion
DK19744779.0T DK3806746T3 (en) 2018-06-14 2019-06-14 SECOND READING SUGGESTIONS
HUE19744779A HUE058907T2 (en) 2018-06-14 2019-06-14 Second reader suggestion
CA3102173A CA3102173A1 (en) 2018-06-14 2019-06-14 Second reader
JP2020568668A JP2021527473A (en) 2018-06-14 2019-06-14 Immediate close inspection
EP19744777.4A EP3806744B1 (en) 2018-06-14 2019-06-14 Immediate workup
PCT/GB2019/051666 WO2019239153A1 (en) 2018-06-14 2019-06-14 Immediate workup
PCT/GB2019/051668 WO2019239155A1 (en) 2018-06-14 2019-06-14 Second reader suggestion
AU2019285394A AU2019285394A1 (en) 2018-06-14 2019-06-14 Second reader suggestion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1809796.4A GB2574659A (en) 2018-06-14 2018-06-14 Immediate workup

Publications (2)

Publication Number Publication Date
GB201809796D0 GB201809796D0 (en) 2018-08-01
GB2574659A true GB2574659A (en) 2019-12-18

Family

ID=63042158

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1809796.4A Withdrawn GB2574659A (en) 2018-06-14 2018-06-14 Immediate workup

Country Status (1)

Country Link
GB (1) GB2574659A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005001740A2 (en) * 2003-06-25 2005-01-06 Siemens Medical Solutions Usa, Inc. Systems and methods for automated diagnosis and decision support for breast imaging
US20130322711A1 (en) * 2012-06-04 2013-12-05 Verizon Patent And Licesing Inc. Mobile dermatology collection and analysis system
WO2016057960A1 (en) * 2014-10-10 2016-04-14 Radish Medical Solutions, Inc. Apparatus, system and method for cloud based diagnostics and image archiving and retrieval
US20160361121A1 (en) * 2015-06-12 2016-12-15 Merge Healthcare Incorporated Methods and Systems for Automatically Selecting an Implant for a Patient

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005001740A2 (en) * 2003-06-25 2005-01-06 Siemens Medical Solutions Usa, Inc. Systems and methods for automated diagnosis and decision support for breast imaging
US20130322711A1 (en) * 2012-06-04 2013-12-05 Verizon Patent And Licesing Inc. Mobile dermatology collection and analysis system
WO2016057960A1 (en) * 2014-10-10 2016-04-14 Radish Medical Solutions, Inc. Apparatus, system and method for cloud based diagnostics and image archiving and retrieval
US20160361121A1 (en) * 2015-06-12 2016-12-15 Merge Healthcare Incorporated Methods and Systems for Automatically Selecting an Implant for a Patient

Also Published As

Publication number Publication date
GB201809796D0 (en) 2018-08-01

Similar Documents

Publication Publication Date Title
US11488306B2 (en) Immediate workup
US11127137B2 (en) Malignancy assessment for tumors
CN109583440B (en) Medical image auxiliary diagnosis method and system combining image recognition and report editing
JP6807820B2 (en) Image search device, method and program
CN107767962B (en) Determining result data based on medical measurement data from different measurements
JP2003524492A (en) Method, system, and computer-readable medium for an intelligent search workstation for computer-aided interpretation of medical images
Sreenivasu et al. Dense convolutional neural network for detection of cancer from CT images
US20230057933A1 (en) Storage medium, diagnosis support apparatus and diagnosis support method
WO2020110519A1 (en) Similarity determination device, method, and program
Zhang et al. Quantification of lung ventilation defects on hyperpolarized MRI: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD study
GB2574659A (en) Immediate workup
WO2022112731A1 (en) Decision for double reader
EP4328855A1 (en) Methods and systems for identifying a candidate medical finding in a medical image and providing the candidate medical finding
Sreenivasu et al. Research Article Dense Convolutional Neural Network for Detection of Cancer from CT Images
CN117711576A (en) Method and system for providing a template data structure for medical reports
CN113450306A (en) Method of providing a fracture detection tool
Mencattini et al. Metrological assessment of a CAD system for the early diagnosis of breast cancer in digital mammography

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)